EMO Capital Seeks Listing on the Plus Exchange in London and Launches its European Website
TORONTO, Jan. 26, 2012 /PRNewswire/ - EMO Capital (NUVI:OTCBB), a publicly traded American company listed on the OTCBB is pleased to announce that is has commenced the process of seeking a listing on London's Plus Stock Exchange and the launch of its new website in the United Kingdom.
The growth of the European marketplace is an integral component of NUVitality's business plan. The inter-listing of the Company on the Plus Stock Exchange will allow European investors a platform to invest into the Company. In addition, the launch of a new website dedicated to European e-commerce and multi-channel retailers seeking Internet sales opportunities in Europe will further enhance the Company's revenue stream. This two prong approach into the European market will expand the geographic reach of not only the company's customers but also, new retailers and shareholders as well.
Nuvitality, focuses on the diet and wellness industry; a market in the UK that alone stands at 63 million people , $1.6 Billion in sales annually and currently has the highest obesity rates in all of Europe.*
According to a new healthcare market research report Global Weight Loss and Gain Market (2009 - 2014)', published by Markets and Markets (www.marketsandmarkets.com), the total global weight loss market is expected to be worth US$586.3 billion by 2014. The market has a compound annual growth rate (CAGR) of 10.9% from 2009 to 2014. NuVitality global focus remains on target to seek a global platform of distributors and clients to take advantage of the growing product line up of the Company's diet and wellness products.
Emo Capital Corp thru its wholly owned subsidiary NuVitality Labs is an international direct marketing corporation specializing in health and wellness categories. www.emocapitalcorp.com
Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend", "dramatically" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in Emo Capital's filings with the Securities and Exchange Commission. In addition, such statements could be affected by risks and uncertainties related to the ability of the company to control product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on Emo Capitals's website does not constitute a part of this release.
*http://www.candis.co.uk/magazine/familyhealthnews/family-health-june-2011
SOURCE Emo Capital
Share this article